US equities
|
NVDA
$240.22
▲+0.55%
SPCX
$173.77
▲+1.57%
MU
$1,062.72
▼-0.12%
MRVL
$280.77
▲+3.51%
AMD
$655.10
▲+3.70%
INTC
$114.26
▼-1.66%
SNDK
$1,670.75
▼-1.96%
AVGO
$377.25
▲+4.07%
NVDA
$240.22
▲+0.55%
SPCX
$173.77
▲+1.57%
MU
$1,062.72
▼-0.12%
MRVL
$280.77
▲+3.51%
AMD
$655.10
▲+3.70%
INTC
$114.26
▼-1.66%
SNDK
$1,670.75
▼-1.96%
AVGO
$377.25
▲+4.07%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
11.47
-0.31 (-2.63%)
Delayed Quote
Updated: 1:06 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
50 Biggest Movers From Yesterday
↗
January 13, 2022
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for...
Via
Benzinga
US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy
↗
January 11, 2022
The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody...
Via
Benzinga
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
↗
December 29, 2021
Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...
Via
Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
↗
December 26, 2021
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key...
Via
Talk Markets
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
↗
December 26, 2021
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...
Via
Benzinga
Xmas Eve
↗
December 24, 2021
About 2000 flights which airlines were proposing to run today have been canceled because of virus not only amongst passengers but also among the crew.
Via
Talk Markets
Plague Year Reversal
↗
December 21, 2021
Just in time for Christmas, the market decided to go up today pretty much across the board.
Via
Talk Markets
55 Biggest Movers From Yesterday
↗
December 22, 2021
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
December 21, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
↗
December 21, 2021
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining...
Via
Benzinga
Alibaba Downgrade, Micron Upgrades Among Today's Top Calls On Wall Street
↗
December 21, 2021
Atlantic Equities analyst James Cordwell downgraded Alibaba to Neutral from Overweight with a price target of $140, down from $185.
Via
Talk Markets
Glaxo-Vir Biotech's Antibody Approved In Europe For Early Treatment Of COVID-19
↗
December 17, 2021
The European Commission (EC) has granted marketing authorization to GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR)...
Via
Benzinga
Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain
↗
December 16, 2021
Two tests from independent labs suggest Adagio's antibody could still target omicron.
Via
Investor's Business Daily
46 Biggest Movers From Yesterday
↗
December 16, 2021
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 15, 2021
Gainers Biofrontera (NASDAQ:
Via
Benzinga
Uncertain Times
↗
December 15, 2021
The UK inflation rate last month was 5.1%, not a good omen.
Via
Talk Markets
Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb
↗
December 15, 2021
Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has...
Via
Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
↗
December 15, 2021
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...
Via
Benzinga
Why Are Vir Biotech Shares Gaining Today?
↗
December 15, 2021
Vir Biotechnology Inc (NASDAQ: VIR) announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic...
Via
Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
↗
December 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 08, 2021
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...
Via
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
↗
December 07, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 123.2% to $6.16. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories....
Via
Benzinga
54 Biggest Movers From Yesterday
↗
December 08, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and...
Via
Benzinga
Investors Do A Little Holiday Value Shopping On Monday
↗
December 07, 2021
The Nasdaq futures were rallying nearly 2% before the open as technology stocks decide to follow the Dow Jones 30. Many stocks rallied on Monday as early data concerning the...
Via
Benzinga
Topics
Stocks
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
↗
December 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 07, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion....
Via
Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
↗
December 07, 2021
Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) rose 23.7% to $3.18 in pre-market trading after jumping 10% on Monday. The company, last month, priced its IPO at $10 per unit....
Via
Benzinga
Topics
Initial Public Offering
Preclinical Data Shows GSK-Vir COVID-19 Drug Works Against All Omicron Mutations
↗
December 07, 2021
GlaxoSmithKline plc (NYSE: GSK) said that its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology Inc (NASDAQ: VIR) is effective against all...
Via
Benzinga
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
↗
December 03, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enbridge Inc. (NYSE:
Via
Benzinga
Apple Issues Negative iPhone 13 Forecast as Boeing Gets "Okay" from China
↗
December 02, 2021
Stock index futures are mixed ahead of the open while investors try to digest yesterday’s selloff. Heavy selling into the close is often seen as a bad sign for stocks, so...
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
